Opus Genetics (OPUS) Files Form 144 on April 23, 2023

AI Summary

Opus Genetics (OPUS) submitted a Form 144 on April 23, 2023, indicating the intention of insiders to sell shares. This filing can signal possible insider selling, which may impact investor sentiment regarding the stock. The Form 144 provides a legal allowance for selling up to 1% of a company's outstanding shares. Monitoring such filings is crucial for understanding the potential market movements for stocks, especially for smaller companies like Opus Genetics.